Profiles of liver fibrosis evolution during long-term tenofovir treatment in HIV-positive patients coinfected with hepatitis B,Liver International

当前位置： X-MOL 学术 › Liver Int. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Profiles of liver fibrosis evolution during long-term tenofovir treatment in HIV-positive patients coinfected with hepatitis B
Liver International ( IF 6.7 ) Pub Date : 2021-07-23 , DOI: 10.1111/liv.15019
Lorenza N C Dezanet ₁ , Patrick Miailhes ₂ , Caroline Lascoux-Combe ₃ , Julie Chas ₄ , Sarah Maylin ₅ , Audrey Gabassi _{5,

6} , Hayette Rougier ₇ , Constance Delaugerre _{5,

6} , Karine Lacombe _{1,

8} , Anders Boyd _{1,

8}

Affiliation

Data on liver fibrosis evolution and its involvement in liver-related morbidity are scarce in individuals with human immunodeficiency virus (HIV) and hepatitis B virus (HBV) co-infection during treatment. We identified profiles of liver fibrosis evolution in coinfected patients undergoing tenofovir (TDF).

中文翻译：